SCHEMBL3514702

SCHEMBL3514702

CCOC(=O)c1cc[n+]([O-])cc1C(=O)OCC

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.56
ALDH1A1 P00352 2/20 0.45
HSD17B10 Q99714 1/20 0.45
CA12 O43570 4/20 0.44
CA1 P00915 4/20 0.44
CA2 P00918 4/20 0.44
CA7 P43166 4/20 0.44
CA9 Q16790 4/20 0.44
CA14 Q9ULX7 4/20 0.44
LMNA P02545 4/20 0.43
CDC25B P30305 1/20 0.42
L3MBTL1 Q9Y468 2/20 0.41
KDM4E B2RXH2 1/20 0.41
ESR1 P03372 1/20 0.41
ESR2 Q92731 1/20 0.41
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
MAOB P27338 1/20 0.40
CYP1A2 P05177 3/20 0.40
CYP2C19 P33261 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27006674 0.88 TSHR (0.50) TSHRALDH1A1HSD17B10CA12CA1
SCHEMBL5743569 0.88 TSHR (0.50) TSHRALDH1A1HSD17B10CA12CA1
SCHEMBL28250511 0.82 ALDH1A1 (0.48) TSHRALDH1A1LMNAKDM4EMEN1
SCHEMBL1011953 0.80 MAPT (0.54) TSHRALDH1A1HSD17B10CA12CA1
SCHEMBL4873097 0.77 CA12 (0.58) ALDH1A1CA12CA1CA2CA7
SCHEMBL2832653 0.76 GABRA1 (0.57) ALDH1A1HSD17B10L3MBTL1KDM4EMEN1
SCHEMBL4862698 0.75 GLA (0.57) TSHRALDH1A1CA12CA1CA2
Diethyl Phthalate SCHEMBL22296 0.73 TSHR (1.00) TSHRALDH1A1HSD17B10CA12CA1
Diethyl Phthalate SCHEMBL29404255 0.73 TSHR (1.00) TSHRALDH1A1HSD17B10CA12CA1
Diethyl Phthalate SCHEMBL5306972 0.73 TSHR (1.00) TSHRALDH1A1HSD17B10CA12CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100056516-A1 1-HYDROXY NAPHTHYRIDINE COMPOUNDS AS ANTI-HIV AGENTS MERCK SHARP & DOHME CORP. 2010-03-04 US disclosed
EP-2044068-A1 1-HYDROXY NAPHTHYRIDINE COMPOUNDS AS ANTI-HIV AGENTS Merck & Co., Inc. (US) 2009-04-08 EP disclosed
WO-2008010964-A1 1-HYDROXY NAPHTHYRIDINE COMPOUNDS AS ANTI-HIV AGENTS MERCK & CO., INC. (US) 2008-01-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100056516-A1 1-HYDROXY NAPHTHYRIDINE COMPOUNDS AS ANTI-HIV AGENTS RNASEH1, RNASE1, RNASEL TSHR 3624/4885ALDH1A1 1486/4885HSD17B10 1361/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.